Observed survival benefit with limited exposure of durvalumab in unresectable stage III non-small cell lung cancer at a large community-based institution von Vadehra, Deepak, Pallas, Christopher R, Moore, Donald, Villadolid, Jeryl Jean, Robinson, Myra M., Mileham, Kathryn Finch, Carrizosa, Daniel R.

Volltext

Impact of Electronically Accessible Pathways (EAPathways) on clinical trial enrollment at a large multisite cancer center von Villadolid, Jeryl Jean, Jandrisevits, Elizabeth, Moore, Donald, Patel, Jai Narendra, Mileham, Kathryn Finch, Kim, Edward S.

Volltext